SCHEMBL375509

SCHEMBL375509

Fc1ccc(OC(F)(F)F)cc1CNC1CCOCC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.44
BCHE P06276 1/20 0.40
ACHE P22303 1/20 0.40
BACE1 P56817 1/20 0.40
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
OPRL1 P41146 2/20 0.40
ADRB2 P07550 1/20 0.40
CARM1 Q86X55 1/20 0.39
PRMT6 Q96LA8 1/20 0.39
TACR1 P25103 6/20 0.39
PDE2A O00408 1/20 0.39
MTOR P42345 1/20 0.38
PDCD1 Q15116 1/20 0.38
CD274 Q9NZQ7 1/20 0.38
PIM1 P11309 4/20 0.38
KCNH2 Q12809 2/20 0.38
CYP2D6 P10635 1/20 0.38
HTR1A P08908 1/20 0.37
HTR2A P28223 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17484533 0.85 TACR1 (0.46) BCHEACHEBACE1ADRB2CARM1
SCHEMBL374832 0.80 BCHE (0.60) BCHEACHEBACE1CARM1PRMT6
SCHEMBL375222 0.78 CARM1 (0.61) BCHEACHEBACE1ALDH1A1CARM1
SCHEMBL375224 0.77 OPRL1 (0.42) PARP1BCHEACHEBACE1ALDH1A1
SCHEMBL22957678 0.76 ADRB2 (0.49) ADRB2KCNH2HTR2A
SCHEMBL375079 0.75 TACR1 (0.51) BCHEACHEBACE1TACR1PDCD1
SCHEMBL375623 0.74 BCHE (0.46) BCHEACHEBACE1ALDH1A1OPRL1
SCHEMBL737348 0.74 ALDH1A1 (0.49) KDM4EALDH1A1PDE2AHTR1A
SCHEMBL24018765 0.73 ADRB2 (0.46) KDM4EADRB2PIM1
SCHEMBL31532434 0.71 P2RX7 (0.42) BCHEACHEBACE1CARM1PRMT6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8623898-B2 Glycine transporter inhibiting substances TAISHO PHARMACEUTICAL CO., LTD. (JP) 2014-01-07 US disclosed
EP-2409976-A1 GLYCINE TRANSPORTER INHIBITOR Taisho Pharmaceutical Co., Ltd. (JP) 2012-01-25 EP disclosed
US-20120010414-A1 GLYCINE TRANSPORTER INHIBITING SUBSTANCES TAISHO PHARMACEUTICAL CO., LTD. (JP) 2012-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010414-A1 GLYCINE TRANSPORTER INHIBITING SUBSTANCES SLC18A2, SLC1A2, SLC6A1 PARP1 4575/4885BCHE 593/4885ACHE 467/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.